CPOW .0003 ^25% All Content and Data provided by

New Post Public Reply Private Reply Replies (0) Message Board
FLA
86
CPOW .0003 ^25%


All Content and Data provided by Third-Parties — Terms of Use
Hemp Technology Inc. Ramps Up its Operations in Latin America
CANADA NEWSWIRE 11:46 AM ET 9/27/2019
Establishes Sol Terra SAS in Colombia

LOUISVILLE, Sept. 26, 2019 /CNW/ - Hemp Technology Inc. ("HempTech" or the "Company" , is pleased to announce it has expanded its operations with the incorporation of Sol Terra SAS in Colombia as it ramps up its expansion into Latin America. Establishing its operations in Bogota is a key milestone in HempTech's evolution as it will leverage the Company's access to global markets. Sol Terra SAS is in the final stages of acquiring a company with necessary licenses for cultivation, manufacture, distribution, and export. The Company now has its operations in two strategic locations, Kentucky, U.S.A. and Colombia.


"Establishing our operations in Colombia provides HempTech with early-mover advantage with access to low cost production, an ideal growing climate, and a skilled agricultural workforce," stated Michael Shenher, CEO.

HempTech has put in place a highly skilled team of management and key advisors in LATAM with considerable connectivity, and expertise in the cultivation, manufacture and distribution of hemp-derived phytocannabinoid products. Establishing operations in Bogota affirms the Company's commitment to developing a full range of high-quality products in one of Latin America's fastest growing economies. This milestone increases the Company's ability to establish key partnerships, and distributor relationships to execute its scalable business model. The operations will accelerate the company's growth efforts in the industry's Latin America market, which could grow to US $12 Billion by 2028E, reflecting a CAGR of 58.4% from 2018 (source: Prohibition Partners Research).

"Establishing our operations in Latin America furthers our strategic plan to produce, manufacture and distribute hemp-derived phytocannabinoids on a global scale. With the expertise of our team in LATAM, we expect to initiate the sales and distribution of high-value hemp-derived CBD isolate and CBD products in 2020," stated Chad Costa, President.

Chad Costa
President
Hemp Technology Inc.

Hemp Technology Inc. (CNW Group/Hemp Technology Inc.)

About Hemp Technology Inc.
Hemp Technology Inc. is striving to become the largest vertically-integrated producer, manufacturer, and distributor of hemp-derived high-value phytocannabinoids in the world. The Company is a B2B, bulk and wholesale supplier of hemp-derived CBD isolate established to serve the rapidly growing global market. HempTech has the executive expertise, and product research and development capabilities to expand its hemp-derived CBD product lines on a global scale.

About Sol Terra SAS
Sol Terra SAS is a Colombian company legally constituted in the Chamber of Commerce of Bogota.

Forward Looking Information

This news release contains "forward-looking statements" within the meaning of applicable securities legislation, such as section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934, including estimates of future sales, cash flows, business plans, the estimated amounts and timing of capital expenditures, the assumptions upon which estimates are based and related sensitivity analyses, and other expectations, beliefs, plans, objectives, assumptions or statements about future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "2019E" "anticipates" or "does not anticipate", "plans", "estimated" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved). By their nature, such forward-looking statements are subject to a number of risks, uncertainties and assumptions, which could cause actual results or other expectations to differ materially from those anticipated, expressed or implied by such statements, including those material risks discussed in the Company's Form 10, and in our Management's Discussion and Analysis. The material assumptions are disclosed in the Management's Discussion and Analysis. In addition, with respect to forward-looking information contained in this presentation, assumptions have been made regarding, among other things: CBD and Hemp commodity pricing, manufacturing efficiency, future interests rates, currency exchange rates and future costs, and availability of financing. These assumptions, risks and uncertainties could cause actual results or other expectations to differ materially from those anticipated, expressed or implied by such statements. The impact of any one assumption, risk, uncertainty or factor on a particular forward looking statement is not determinable with certainty as these are interdependent. Except as required by law, Hemp Technology Inc. assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change. Certain information contained herein has been prepared by third-party sources. To the extent such estimates constitute a "financial outlook" or "future oriented financial information" in this presentation, as defined by applicable securities legislation, such information has been approved by management of Hemp Technology Inc. Such financial outlook or future oriented financial information is provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hemp-technology-inc-ramps-up-its-operations-in-latin-america-300926965.html

SOURCE Hemp Technology Inc.
















CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW CPOW
I ONLY POST WHAT I PLAY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading